Our verdict
Katalyze Data is a credible alternative for a pharma team buying a validated analytical environment and its ongoing operation. Statilyze makes the infrastructure and governance scope concrete. It is a less direct match for a standalone, highly customized Shiny interface, where application-development references matter more than platform deployment.
The right buyer
- Clinical organizations that need a managed GxP statistical computing environment.
- Teams modernizing SAS while adding R and Python under common governance.
Reasons to look elsewhere
- A pure Shiny product build needs separate confirmation of application-design depth.
- The customer should separate software licenses, validation changes, and managed-service responsibilities in the scope.
Katalyze Data, At A High Level
Katalyze Data was previously Amadeus Software and adopted its current name in 2023. The business traces its history to 1989. Its work spans data strategy, analytics-platform design, migration, managed services, and training. Statilyze brings SAS, R, and Python into a governed environment with access controls, audit trails, and version control. Cloud and on-premises deployment are offered. The firm describes validation against GxP, 21 CFR Part 11, and GAMP 5; the precise intended use and change-control obligations still belong in the client’s validation plan. This is a consulting and operating service around clinical computing, not merely a package of analytics software.
Scores by criterion
| Criterion | Weight | Score | Basis |
|---|---|---|---|
| Production track record | 20% | 7.0 | Long operating history and an explicit clinical computing product; outcome evidence is supplier-led. |
| Technical depth | 15% | 8.0 | SAS, R, Python, cloud/on-premises infrastructure, and validation controls. |
| Industry depth | 10% | 8.5 | Statilyze targets clinical trials and regulatory submissions. |
| Delivery model and handoff | 15% | 8.0 | Managed operation, migration, deployment, and training form a coherent offer. |
| Commercial clarity | 10% | 6.0 | The deployment model is explained; total implementation and support fees need scoping. |
| Platform independence | 10% | 7.0 | Multiple languages and infrastructure choices, with substantial SAS and Posit specialization. |
| Stability and scale | 10% | 7.0 | The predecessor business dates to 1989 and retains named technical leadership. |
| Independent evidence | 10% | 5.5 | Most implementation and compliance evidence is the firm’s own documentation. |
| Overall | 100% | 7.2 | Weighted average |
Source: AI Services Companies editorial assessment of Home, Statilyze.
Where Katalyze Data fits
Pharmaceutical companies, CROs, and clinical research groups use the managed-environment offer. Katalyze occupies the specialist platform-consulting tier, with ongoing managed services as well as implementation. A comparison with an application shop is valid for the regulated environment workstream, but not automatically for every front-end development project.
For the same work, compare Appsilon for regulated Posit and R infrastructure plus application delivery; Atorus Research for validated clinical analytics environments and programming; Jumping Rivers for R validation, infrastructure, and training.
What clients and leaders say
Client statements below describe their own engagements. Service-description quotations are the firm’s own words, not customer reviews.
“Statilyze is a fully managed, validated statistical computing environment built for pharmaceutical and clinical organisations.”
“Cloud or on-premises deployment to fit your infrastructure and data residency requirements”
“We specialise in designing, deploying and managing data platforms and solutions for regulated organisations.”
What people may not like
A pure Shiny product build needs separate confirmation of application-design depth. The customer should separate software licenses, validation changes, and managed-service responsibilities in the scope.
